News for Arix Bioscience plc (3HY.F)

Published at

Feb 11, 2021 9:00 AM

by prnewswire.com

neutral

neutral

Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients

/PRNewswire/ -- Artios Pharma Limited ("Artios"), a leading DNA Damage Response (DDR) company developing a broad pipeline of precision medicines for the...

MRK1N.MX MRK.SG MRK.MU MRK.F MRK.DE MRK.BE MKGAF IPO.L IOOA.F ARIX.L 3HY.F

Read more →
Published at

Feb 11, 2021 9:00 AM

by markets.businessinsider.com

neutral

neutral

Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients

- Artios Pharma transitions to a clinical-stage precision medicine company - Advances next generation DNA Damage Response (DDR) treatment targetin...

MRK1N.MX MRK.SG MRK.MU MRK.F MRK.DE MRK.BE MKGAF IPO.L IOOA.F ARIX.L 3HY.F

Read more →
Published at

Feb 11, 2021 9:00 AM

by markets.businessinsider.com

neutral

neutral

Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients

CAMBRIDGE, England and NEW YORK, Feb. 11, 2021 /PRNewswire/ -- Artios Pharma Limited ('Artios'), a leading DNA Damage Response (DDR) company devel...

MRK1N.MX MRK.SG MRK.MU MRK.F MRK.DE MRK.BE MKGAF IPO.L IOOA.F ARIX.L 3HY.F

Read more →
Published at

Jan 18, 2021 5:46 PM

by marketscreener.com

mixed

mixed

Proactive news headlines: Oriole Resources, Faron Pharma, One Media iP Group, IQGeo Group …

Oriole Resources PLC has updated investors on the current work programmes on its West African projects during the first quarter of 2021. In Senegal, IAMGOLD has completed its... | January 18, 2021

WTE.L WMELF W6M.SG W6M.F UJO.L SRES.L SBI.L S4D.F S4D.BE RMS.L PERE.L OMIP.L NQMLF KYYWF KWS.L KS3.F KS3.BE IQG.L IPO.L IOOA.F FARN.L CMCL.L CMCL BBH.L ARIX.L ARBKF ARB.L 9CD1.SG 9CD1.F 6J8.F 67B.SG 67B.F 3HY.F 0XP.MU 0XP.F 0XP.BE W1D.F SO4.AX S1Y.F S1Y.BE PP51.F PP51.BE PHP.L ORR.L IRR.L IMM.L GDR.L EUZ.L EUZ.JO D6M.F D6M.BE BSG.F AEXG.L AEX.V 2NQ.F 25I.MU 25I.F 25I.BE ICON.L GENL.L GEGYY GEGYF 4VL.MU 4VL.F 4VL.BE

Read more →
Published at

Jan 6, 2021 3:01 PM

by marketscreener.com

neutral

neutral

Arix Bioscience : Imara reports Phase 2a clinical trial results of -2-

Biomarker results in IMR-687+HU treated patients showed an overall increase in F-cells and HbF levels from baseline to week 24, while Hb levels did not meaningfully change. Three of the eight... | January 6, 2021

IMRA FN ARIX.L 3HY.F

Read more →

News for Arix Bioscience plc (3HY.F)

Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients

Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients

Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients

Proactive news headlines: Oriole Resources, Faron Pharma, One Media iP Group, IQGeo Group …

Arix Bioscience : Imara reports Phase 2a clinical trial results of -2-